Topics: Public Health and Medicine

[ULWPQSF id=3563]

A hole in one – will sports and CBD continue to entwine?

8th August 2019 - Business briefing |

Canada
North America
United States
Companies
Marketing and Retailing
Public Health and Medicine
Technology and Innovation
Business briefing

The sports world is becoming increasingly enamoured with CBD. US professional golfers have become the latest sporting personalities to endorse CBD products, including 2009 US Open winner Lucas Glover.
Will CBD continue to wind its way into the professional sporting arena in the US and Canada – and even further afield?

CBD-Intel bonus midweek regulatory alerts, 8th August 2019

8th August 2019 - Regulatory briefing |

Africa
Canada
Colombia
EU
Europe
Mexico
North America
South America
United States
Zimbabwe
Companies
Marketing and Retailing
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Regulatory briefing

CBD-Intel’s regular round-up of regulatory news features items from Portugal, the UK, Germany, Italy, Denmark, North America, Mexico, Colombia and Zimbabwe

Regulatory tracker: current global regulation of CBD August 2019

8th August 2019 - Regulatory trackers |

Afghanistan
Africa
Alabama
Alaska
Albania
Algeria
Andorra
Argentina
Arizona
Arkansas
Armenia
Armenia
Asia
Australasia
Australia
Austria
Bahrain
Bangladesh
Belarus
Belgium
Bosnia and Herzegovina
Brazil
Bulgaria
California
Cambodia
Canada
Chile
China
Colombia
Colorado
Connecticut
Croatia
Cyprus
Czech Republic
Delaware
Democratic Rep. of the Congo
Denmark
Ecuador
Egypt
England
Estonia
Ethiopia
EU
Europe
Finland
Florida
France
Georgia
Georgia
Germany
Greece
Hawaii
Honduras
Hong Kong
Hungary
Iceland
Idaho
Illinois
India
Indiana
Indonesia
Iowa
Iran
Iraq
Ireland
Isle of Man
Israel
Italy
Japan
Kansas
Kazakhstan
Kentucky
Kenya
Kosovo
Kuwait
Kyrgyzstan
Latvia
Libya
Lithuania
Louisiana
Luxemburg
Macedonia
Maine
Malaysia
Malta
Maryland
Massachusetts
Mauritania
Mexico
Michigan
Middle East
Minnesota
Mississippi
Missouri
Moldova
Monaco
Montana
Montenegro
Morocco
Mozambique
Myanmar
Namibia
Nebraska
Nepal
Netherlands
Nevada
New Hampshire
New Jersey
New Mexico
New York
New Zealand
Nigeria
North America
North Carolina
North Dakota
North Korea
Northern Ireland
Norway
Ohio
Oklahoma
Oman
Oregon
Pakistan
Pennsylvania
Peru
Philippines
Poland
Portugal
Qatar
Rhode Island
Romania
Russia
San Marino
Saudi Arabia
Scandinavia
Scotland
Serbia
Singapore
Slovakia
Slovenia
South Africa
South America
South Carolina
South Dakota
South Korea
Spain
Sri Lanka
Sudan
Sweden
Switzerland
Syria
Taiwan
Tanzania
Tennessee
Texas
Thailand
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Utah
Uzbekistan
Vatican City
Venezuela
Vermont
Vietnam
Virginia
Wales
Washington
Washington D.C.
West Virginia
Wisconsin
World
Wyoming
Yemen
Zimbabwe
Marketing and Retailing
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Regulatory trackers

Welcome to the CBD-Intel global regulatory tracker, updated each month. Use the tabs at the top of the map to select a specific regulatory field. Clicking on an individual country will bring up much more detail in the panel below, including links to legislation and CBD-Intel coverage of that market. Updates for August 2019: New […]

CBD-Intel regulatory news in brief

5th August 2019 - Regulatory briefing |

Africa
Arizona
Canada
EU
Europe
Germany
Italy
Luxemburg
Netherlands
North America
North Carolina
Ohio
South Africa
South Carolina
Spain
United States
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Regulatory briefing

CBD-Intel’s regular round-up of regulatory news features items from Germany, Italy, France, the Netherlands, Spain, Luxembourg, Canada, the US and South Africa

Epidyolex takes huge step toward EU licensing

31st July 2019 - Regulatory briefing |

EU
Europe
Companies
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Regulatory briefing

A European review committee has recommended that British company GW Pharmaceuticals’ Epidyolex (known as Epidiolex in the US) be licensed as a medicine in the European Union.

CBD-Intel business news in brief, 22nd-26th July 2019

29th July 2019 - Business briefing |

California
Canada
Connecticut
Europe
Nevada
New York
North America
United Kingdom
United States
Companies
Marketing and Retailing
Public Health and Medicine
Business briefing

Can CBD affect fertility in mice and men? CBD-Intel brings you this and other stories in our regular round-up of business snippets

CBD-Intel regulatory news in brief

22nd July 2019 - Regulatory briefing |

Asia
California
China
Czech Republic
EU
Europe
France
Germany
Ireland
Italy
Latvia
North America
Ohio
United States
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Regulatory briefing

CBD-Intel’s regular round-up of regulatory snippets features news from the US, Europe and China

CBD to help with sleep, OCD, and cocaine use? Science news in brief

13th June 2019 - Regulatory briefing |

Canada
Europe
New York
North America
Spain
United States
Washington
Public Health and Medicine
Technology and Innovation
Regulatory briefing

Recent studies show cannabinoids could help with sleep disorders, obsessive compulsive disorder (OCD), and cocaine addiction, while genetic research could help regulators delineate between cannabis strains

CBD business news in brief,
3rd-10th June

10th June 2019 - Business briefing |

Arizona
California
Canada
Kentucky
New York
North America
United States
Companies
Public Health and Medicine
Technology and Innovation
Business briefing

Catch up on the latest CBD business news with CBD-Intel’s weekly round-up

Is the NFL about to relax its stance on CBD?

4th June 2019 - Business briefing |

North America
United States
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Business briefing

CBD continues to gain ground across sports in North America; with recent visibility in sports like rugby and baseball, and no general proscription against CBD use from the World Anti-Doping Code, it may be making headway into American football.

CBD business news in brief: worldwide, 27-31st May

3rd June 2019 - Business briefing |

Afghanistan
Africa
Alabama
Alaska
Albania
Algeria
Andorra
Argentina
Arizona
Arkansas
Armenia
Armenia
Asia
Australasia
Australia
Austria
Bahrain
Bangladesh
Belarus
Belgium
Bosnia and Herzegovina
Brazil
Bulgaria
California
Cambodia
Canada
Chile
China
Colombia
Colorado
Connecticut
Croatia
Cyprus
Czech Republic
Delaware
Democratic Rep. of the Congo
Denmark
Ecuador
Egypt
England
Estonia
Ethiopia
EU
Europe
Finland
Florida
France
Georgia
Georgia
Germany
Greece
Hawaii
Honduras
Hong Kong
Hungary
Iceland
Idaho
Illinois
India
Indiana
Indonesia
Iowa
Iran
Iraq
Ireland
Isle of Man
Israel
Italy
Japan
Kansas
Kazakhstan
Kentucky
Kenya
Kosovo
Kuwait
Kyrgyzstan
Latvia
Libya
Lithuania
Louisiana
Luxemburg
Macedonia
Maine
Malaysia
Malta
Maryland
Massachusetts
Mauritania
Mexico
Michigan
Middle East
Minnesota
Mississippi
Missouri
Moldova
Monaco
Montana
Montenegro
Morocco
Mozambique
Myanmar
Namibia
Nebraska
Nepal
Netherlands
Nevada
New Hampshire
New Jersey
New Mexico
New York
New Zealand
Nigeria
North America
North Carolina
North Dakota
North Korea
Northern Ireland
Norway
Ohio
Oklahoma
Oman
Oregon
Pakistan
Pennsylvania
Peru
Philippines
Poland
Portugal
Puerto Rico
Qatar
Rhode Island
Romania
Russia
San Marino
Saudi Arabia
Scandinavia
Scotland
Serbia
Singapore
Slovakia
Slovenia
South Africa
South America
South Carolina
South Dakota
South Korea
Spain
Sri Lanka
Sudan
Sweden
Switzerland
Syria
Taiwan
Tanzania
Tennessee
Texas
Thailand
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Utah
Uzbekistan
Vatican City
Venezuela
Vermont
Vietnam
Virginia
Wales
Washington
Washington D.C.
West Virginia
Wisconsin
World
Wyoming
Yemen
Zimbabwe
Marketing and Retailing
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Technology and Innovation
Business briefing

Catch up on the latest CBD business news with CBD-Intel’s weekly round-up of stories.

CBD business news in brief: worldwide, 20-24th May 2019

27th May 2019 - Business briefing |

Canada
Colorado
Europe
Indiana
North America
Puerto Rico
Spain
United Kingdom
United States
Marketing and Retailing
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Technology and Innovation
Business briefing

Catch up on the latest CBD business news with CBD-Intel’s weekly round-up of stories.

Martial arts company to help research use of CBD for athletes

24th May 2019 - Business briefing |

Canada
North America
United States
Marketing and Retailing
Public Health and Medicine
Business briefing

Aurora Cannabis is to collaborate with Ultimate Fighting Championship (UFC), a mixed martial arts promotions company headquartered in Las Vegas, on studies of CBD’s possible usefulness in treating pain and inflammation and in recovery and wellbeing.

Mainstream US drugstore chains announce plans to sell CBD

29th March 2019 - Business briefing |

Alabama
California
Colorado
Illinois
Indiana
Kentucky
Maryland
New Mexico
North America
Oregon
South Carolina
Tennessee
United States
Vermont
Companies
Marketing and Retailing
Policy and Politics
Public Health and Medicine
Business briefing

CBD products appears to be entering the mainstream of US retail. One of the largest retail pharmacy chains in the US, CVS is already selling a range of products in at least eight US states and Walgreens has announced plans to sell the product in nine states.

Philippines moves one step closer to legalising medical cannabis

29th March 2019 - Regulatory briefing |

Asia
Philippines
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Regulatory briefing

The Philippines moved one step closer to legalising cannabis for medical use when a bill was approved on its final reading, but its progress to law could be scuppered by opposition from president Rodrigo Duterte.

GW Pharmaceuticals reports loss despite success of CBD-based drug

1st March 2019 - Business briefing |

England
Europe
North America
United Kingdom
United States
Companies
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Technology and Innovation
Business briefing

CBD drug manufacturer GW Pharmaceuticals saw a significant net loss in the last quarter, despite growth and sales of its cannabis-derived pharmaceutical drugs going to plan

CBD in foods: UK FSA set to issue guidance

1st March 2019 - Regulatory briefing |

England
Europe
United Kingdom
Wales
Marketing and Retailing
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Regulatory briefing

The UK Food Standards Agency (FSA) will issue further guidance next week on the use of cannabinoids as novel food ingredients

FDA sets the date for hearing on legalising hemp-derived CBD

1st March 2019 - Regulatory briefing |

California
Maine
North America
United States
Wisconsin
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Regulatory briefing

The US Food and Drug Administration (FDA) has set a tentative date of sometime in April for a long-awaited public meeting to hear from stakeholders and begin a rulemaking process on legalising hemp-derived CBD, according to FDA Commissioner Scott Gottlieb

Global CBD rules will get tougher, then normalise, expert predicts

20th February 2019 - Business briefing |

Europe
France
North America
United States
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Business briefing

Regulations governing hemp-derived CBD are likely to increase sharply in the near future but then tail off as the product is integrated into general regulatory frameworks for food, cosmetics and industrial products, according to a legal expert

Argentina – land of opportunity beset by confusion and doubt

29th January 2019 - Business briefing |

Argentina
South America
Companies
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Business briefing

A growing domestic CBD consumer base and excellent potential for cannabis farming make Argentina an intriguing market despite regulatory ambiguity and differences in opinion between national and provincial authorities

CBD classed as pharmaceutical product: Taiwan regulatory report

24th January 2019 - Regulatory reports |

Asia
Taiwan
Marketing and Retailing
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Regulatory reports

In our report looking at the regulations governing CBD in Taiwan, we find that CBD is a classified as a pharmaceutical product and the growing of cannabis plants for any purposes, and the addition of CBD to cosmetic products, is prohibited

LloydsPharmacy may be path to stronger CBD for UK supermarkets

21st January 2019 - Business briefing |

England
EU
Europe
Northern Ireland
Scotland
United Kingdom
Wales
Companies
Marketing and Retailing
Public Health and Medicine
Business briefing

Though Lloyds is a lesser name than Boots among UK pharmacy chains, its partnership with Sainsbury’s means it could be poised to dramatically expand the range of the supermarket’s CBD product offerings.
LloydsPharmacy started stocking a range of CBD products in October last year.